Clinical Trial Update: T-cell Based Immunotherapy for of Melanoma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the Phase 1/2 evaluation of a T-cell–based immunotherapy for melanoma, with the study status listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Inge Marie Svane | Conditions: Melanoma | Phase 1, Phase 2 | Status: COMPLETED